Linked Life Data

7044788

Source:http://linkedlifedata.com/resource/pubmed/id/7044788

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-8-26
pubmed:abstractText
A double-blind study showed that four weekly intra-articular injections of 4 mg orgotein were superior to four weekly injections of saline in reducing pain, the duration of morning stiffness and effusions in patients with osteoarthritis. Forty patients with active osteoarthritis of the knee joint were studied. Patients without demonstrable effusion in the joint to be injected were excluded from the study. They were assigned at random to two treatment groups. The treatments appeared identical and the trial was therefore double-blind. The groups were well matched for age, sex, duration of disease and most other measurements made at the start of the study. Orgotein was safe and well tolerated. It caused only slightly more adverse reactions than placebo. Patients receiving orgotein showed no greater radiological deterioration than those receiving placebo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0140-1610
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
212-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Orgotein in osteoarthritis of the knee joint.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial